GlassScriptPhysician profile
Rachel George
NPI 1972792422
$1,232.40
in general payments reported to CMS, 2019-2025
16 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.99 · 2022: $272 · 2023: $679 · 2024: $81.42 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $947.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $400.80 | 2022-2024 | |
| Amneal Pharmaceuticals LLC | $169.02 | 2023 | Rytary |
| Janssen Biotech, INC. | $124.52 | 2025 | Rybrevant, Carvykti |
| Sk Life Science, INC. | $92.66 | 2023 | |
| Boston Scientific Corporation | $65.12 | 2021-2023 | Wavewriter Alpha Prime 16 |
| Neurocrine Biosciences, INC. | $62.08 | 2023 | Ingrezza, Ongentys |
| Lilly USA, LLC | $60.97 | 2023-2025 | Verzenio, Amyvid, Jaypirca |
| Sumitomo Pharma America, INC. | $51.48 | 2023 | Aptiom |
| Spr Therapeutics, INC | $36.29 | 2024-2025 | Sprint Pns System |
| Janssen Pharmaceuticals, INC | $33.60 | 2022 | |
| Biogen, INC. | $29.80 | 2023 | Plegridy |
| Alexion Pharmaceuticals, INC. | $23.26 | 2022 | |
| Merck Sharp & Dohme LLC | $22.86 | 2025 | Keytruda, Lynparza |
| Idorsia Pharmaceuticals US INC | $21.39 | 2023 | Quviviq |
| Medtronic, INC. | $20.76 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.79 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.